tiprankstipranks
Dmk Pharmaceuticals Corporation (DMKPQ)
:DMKPQ
US Market

DMK Pharmaceuticals (DMKPQ) Income Statement

Compare
1,113 Followers

DMK Pharmaceuticals Income Statement

Last quarter (Q3 2023), DMK Pharmaceuticals's total revenue was $9.06K, a decrease of -99.40% from the same quarter last year. In Q3, DMK Pharmaceuticals's net income was $-1.39M. See DMK Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 4.76M$ 2.21M$ 2.78M$ 22.11M$ 15.09M
Gross Profit
$ -2.90M$ -4.66M$ -3.55M$ 6.44M$ 2.19M
Operating Expenses
$ 22.16M$ 27.41M$ 28.13M$ 36.44M$ 42.54M
Depreciation and Amortization
$ 1.47M$ 1.43M$ 2.33M$ 2.96M$ 3.10M
EBITDA
$ -23.58M$ -30.63M$ -33.51M$ -25.07M$ -37.02M
Operating Income
$ -25.06M$ -32.07M$ -31.68M$ -30.00M$ -40.35M
Other Income/Expenses
$ -1.14M$ -2.53M$ 498.40K$ 1.19M$ 77.12K
Pretax Income
$ -26.20M$ -34.60M$ -35.84M$ -28.16M$ -40.28M
Net Income
$ -26.48M$ -45.83M$ -49.39M$ -27.51M$ -39.01M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -12.37$ -22.25$ -44.57$ -36.16$ -69.86
Diluted EPS
$ -12.37$ -22.25$ -44.57$ -36.16$ -69.86
Weighted Average Shares Outstanding
2.14M 2.06M 1.11M 760.91K 558.36K
Weighted Average Shares Outstanding (Diluted)
2.14M 2.06M 1.11M 760.91K 558.36K
Currency in USD

DMK Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis